Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
E.StevensonM
12(21): 2906-2912.CrossRef PubMed Gu L, Mooney DJ
Beinaglutide showed significant weight-loss benefit and effective glycaemic control for the treatment of type 2 diabetes in a real-world setting: a 3-month, multicentre, observational, retrospective, open-label study
indicated that, in patients with T2DM, albiglutide did not increase adverse AF events and was instead associated with a trend toward reduced AF incidence during follow-up, although this relationship did not achieve statistical significance (135)
US$ 28.87
US$ 20.70
US$ 27.89
US$ 21.25
